Keppel DC REIT (SGX:AJBU)

CTI BioPharma Ratios and Metrics

Market cap in millions SGD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,235	4,816	3,357	3,042	4,237	4,589
Market Cap Growth	69.49%	43.46%	10.35%	-28.21%	-7.66%	35.16%
Enterprise Value	6,626	6,114	4,716	4,256	5,296	5,498
Last Close Price	2.32	2.12	1.76	1.52	2.04	2.23
PE Ratio	14.38	16.02	28.32	13.17	13.51	27.29
PS Ratio	14.36	15.52	12.30	11.34	15.69	17.28
PB Ratio	1.44	1.41	1.43	1.24	1.81	2.32
P/OCF Ratio	22.99	21.53	15.93	13.94	22.13	19.53
EV/Sales Ratio	18.18	19.70	17.28	15.86	19.61	20.70
EV/EBIT Ratio	25.62	27.94	23.09	20.26	24.54	26.00
Debt / Equity Ratio	0.44	0.50	0.63	0.60	0.56	0.61
Asset Turnover	0.08	0.07	0.07	0.07	0.08	0.09
Quick Ratio	1.71	1.10	1.37	1.03	1.12	1.28
Current Ratio	1.81	1.16	1.41	1.07	1.19	1.30
Return on Equity (ROE)	11.26%	10.86%	5.08%	9.77%	14.89%	8.84%
Return on Assets (ROA)	3.43%	2.86%	3.15%	3.33%	3.78%	4.21%
Return on Capital (ROIC)	3.57%	3.04%	3.28%	3.47%	3.95%	4.39%
Earnings Yield	6.23%	6.24%	3.53%	7.59%	7.40%	3.66%
Dividend Yield	4.13%	4.45%	5.33%	6.71%	4.83%	4.11%
Payout Ratio	51.19%	50.87%	148.21%	63.61%	58.01%	61.42%
Buyback Yield / Dilution	-17.39%	-2.25%	-0.16%	-3.32%	-1.81%	-15.15%
Total Shareholder Return	-13.26%	2.20%	5.17%	3.38%	3.02%	-11.03%

Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.